Jeonju

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• Myeloproliferative neoplasms1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals3 trials

Running trials

• Recruiting

  A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  NCT07357727· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

  NCT05217810· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A 24-week rPMS Study in Real-world Setting for Enerzair

  NCT05274425· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms1 recruiting